Article Versions Notes

Wang L, Chapple DE, Kuo H-T, Kurkowska S, Wilson RP, Lau WS, Ng P, Uribe C, Bénard F, Lin K-S. Novel ¹⁷⁷Lu-Labeled [Thz¹⁴]Bombesin(6–14) Derivatives with Low Pancreas Accumulation for Targeting Gastrin-Releasing Peptide Receptor-Expressing Cancer. Pharmaceuticals. 2025; 18(4):449. https://doi.org/10.3390/ph18040449

Wang, Lei, Devon E. Chapple, Hsiou-Ting Kuo, Sara Kurkowska, Ryan P. Wilson, Wing Sum Lau, Pauline Ng, Carlos Uribe, François Bénard, and Kuo-Shyan Lin. 2025. "Novel ¹⁷⁷Lu-Labeled [Thz¹⁴]Bombesin(6–14) Derivatives with Low Pancreas Accumulation for Targeting Gastrin-Releasing Peptide Receptor-Expressing Cancer" Pharmaceuticals 18, no. 4: 449. https://doi.org/10.3390/ph18040449

Wang, L., Chapple, D. E., Kuo, H.-T., Kurkowska, S., Wilson, R. P., Lau, W. S., Ng, P., Uribe, C., Bénard, F., & Lin, K.-S. (2025). Novel ¹⁷⁷Lu-Labeled [Thz¹⁴]Bombesin(6–14) Derivatives with Low Pancreas Accumulation for Targeting Gastrin-Releasing Peptide Receptor-Expressing Cancer. Pharmaceuticals, 18(4), 449. https://doi.org/10.3390/ph18040449